We aim to optimise gynaecological and sexual reproductive health for all, thereby enhancing lifelong well-being and reducing health inequalities for women, girls, babies, and society. To achieve this aim, we study four key areas:Abnormal uterine bleedingEndometriosis and pelvic painGynaecologic and breast cancerSexual and reproductive health Abnormal uterine bleeding Our researchers Principal Investigators: Hilary Critchley, Jackie Maybin, Neil RobertsClinical Lecturers: Varsha JainCritchley research groupMaybin research group Research focuses Determine the biological mechanisms that underpin the symptom of abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).Provide earlier diagnosis of the underlying causes (including uterine fibroids and adenomyosis) of AUB/ HMB.Optimise treatments for AUB/HMB and to make them personalised, more effective, and with fewer side effects HOPE Healthy Optimal Periods for Everyone HOPE is a website all about periods and menstrual health. It provides accurate, accessible information for those who menstruate, their families, doctors, employers and policy makers. In addition, the website provides resources for educators to facilitate the conversation about menstruation with both boys and girls at a young age to increase awareness and destigmatise this physiological process. Endometriosis and pelvic pain Our researchers Principal Investigators: Douglas Gibson, Andrew Horne, Philippa Saunders, Lucy WhitakerGibson research groupHorne research groupSaunders research groupWhitaker research group Research focuses Improve our understanding of the mechanisms that contribute to the aetiology of endometriosisUnderstand why symptoms vary between individualsDevelop and accumulate information that can inform personalised approaches to symptom management. EXPPECT EXPPECT brings together individuals involved in the clinical care of women with pelvic pain and endometriosis with discovery and data scientists, to form a hub within which innovative approaches to pelvic pain treatment can be developed in collaboration with commercial partners. Gynaecologic and breast cancer Our researchers Principal Investigators: Takanori Kitamura, Florent PetitprezClinical lecturers: Neil RyanKitamura research group Research focuses Better understand the preventable drivers of gynaecologic cancers to stop their development at the earliest stageCreate novel, minimally invasive or non-invasive diagnostic methods to detect these malignancies and precursors earlyBetter characterise and understand the tumour microenvironments of endometrial, ovarian, and breast cancer Sexual and reproductive health Our researchers Principal Investigators: Sharon Cameron, Kate Cuschieri, Chelsea MorroniClinical Lecturers: John Reynolds-WrightCameron research groupCuschieri research groupMorroni research group Research focuses Enable ‘real’ reproductive autonomy through quality understandable information on options for avoiding unintended pregnancy as well as overcoming barriers to accessing quality contraception care, especially after pregnancy.Expand contraception options with new, effective methods with fewer side effects and more health benefits. This includes on demand contraception an methods which work after ovulation. Our approaches Build a strong research foundation We have developed an extensive bioresource of patient samples, including tissue, cells, blood, saliva, urine, and faeces. These samples support a pipeline of translational research, spanning patient surveys, in vitro assays, model systems (including a highly cited mouse model), the identification of new targets, and clinical trials.Human Tissue ResourceACCORD Translate research to practise Our diverse faculty, consisting of scientists, clinician-scientists, trialists, and health service researchers, enables us to translate research from bench to bedside and beyond. We have strong integration with NHS Lothian, ensuring that our findings are directly relevant to clinical practice. Public and patient engagement is fundamental to our research and its impact on healthcare and society. Gynaecology - NHS Lothian Utilise cutting-edge technologies We employ state-of-the-art techniques such as single cell/nucleus and spatial transcriptomics, multiplex immunostaining, digital/partitioning PCR, and spectral cytometry. These advanced technologies are integral to our research pipeline, helping to drive progress in understanding disease mechanisms and identifying new biomarkers/therapeutic targets.IRR Core Technologies Collaborate with partnerships and interdisciplinary research We collaborate across disciplines and sectors to investigate epidemiology, risk factors, and the underlying molecular and cellular mechanisms of gynaecologic diseases. By working closely with various scientific, clinical, and public health experts, we aim to foster synergies that lead to innovative solutions and improved health outcomes. Additionally, we study behavioural and complex interventions to empower individuals to make informed health choices.CRH centre partnerships Note: While a large part of the population who experience periods are women and girls, we acknowledge that many transgender, nonbinary, intersex, and gender-nonconforming individuals menstruate but do not identify as women or girls. In addition, we know that many people who do identify as women or girls do not menstruate, due to age, medical conditions, pregnancy, breastfeeding, or use of contraceptives. Our research intends to be inclusive of all of these groups – women who menstruate, women who do not menstruate, and people who menstruate who are not women. Therefore, we use a combination of “women/girls” and “people who menstruate” for our work in this area with the aim of being inclusive and accurate. This article was published on 2025-04-15